B (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

+Studies in 2000-2009 List
*Studies in Pre-2000 List

BACK PAIN + (See Also PAIN, SPASTICITY, SPINAL CHORD INJURY)
BENIGN PROSTATIC HYPERTROPHY (See PROSTATIC HYPERTROPHY)
BILE/BILE DUCTS +
BIMODAL/PARADOXICAL EFFECTS (A High Dose And a Low Dose Give Very Different Effects)
BIPOLAR DISORDER*+
BLADDER/URINARY FUNCTIONS*+
BLEPHAROSPASM (See BLEPHAROSPASM 2000-2009 and MEIGE’S SYNDROME in PRE-2000)
BLISTERS/BLISTERING
BLOOD-BRAIN BARRIER +
BLOOD/PLATELETS/PLASMA*+
BLOOD PRESSURE/VASORELAXATION*+
BONES (See OSTEOPOROSIS/BONES and CARTILAGE)
BONE CEMENT IMPLANTATION SYNDROME (See HIP REPLACEMENT, 2000-2009 Section)
BONE MARROW
BORDERLINE PERSONALITY DISORDER
BORNA DISEASE + (Viral Encephalitic Disease of Warmblooded Animals, No Known Human Cases)
BOWEL DISORDERS*+ (See Also GERD, COLITIS, IBS, CROHN’S DISEASE)
BRAIN CELLS (See NEURONS)
BRAIN–MENTAL EFFECTS (See COGNITIVE EFFECTS/IQ/MEMORY)
BRAIN*+
BRAIN TRAUMA*+ (See Also CHRONIC TRAUMATIC ENCEPHALOPATHY)
BREASTFEEDING/LACTATION/INFANT APPETITE*+
BRUEGHEL’S SYNDROME (See MEIGE’S SYNDROME [Pre-2000 List])
BULIMIA +
BURNING MOUTH SYNDROME
BURN INJURIES +
BUSINESS OF CANNABIS/CANNABIS JOBS


BACK PAIN
Investigational pharmacology for low back pain (full-2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3004649/?toolmcentrez
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22354705
Pot a Common Remedy to Ease Back Pain (news–2013) http/www.medpagetoday.com/MeetingCoverage/AdditionalMeetings/42228
Monterey County seniors finding pain relief in medical marijuana (news–2014) http://www.montereyherald.com/seniors/ci_26440666/monterey-county-seniors-finding-pain-relief-medical-marijuana?source=rss
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news-2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview–2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
How can medical marijuana help with …. BACK PAIN? (news–2015) https://mjwellness.com/news/how-can-medical-marijuana-help-with-back-pain


BILE/BILE DUCTS
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5- HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion (link to PDF–2010) http/www.europeanreview.org/article/724
Distribution of free and conjugated cannabinoids in human bile samples (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22980143
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
Bile salt recognition by human liver fatty acid binding protein (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25639618
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full – 2015) http://ajpendo.physiology.org/content/308/7/E583.long
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP secretion from enteroendocrine K-cells in response to fat ingestion (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25628425
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury (full–2015) http://dmd.aspetjournals.org/content/43/11/1751.long
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
Bile Acid Recognition by NAPE-PLD (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acschembio.6b00624
Distribution of Synthetic cannabinoids JWH-210, RCS-4 and ∆ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834143
top


BIMODAL/PARADOXICAL EFFECTS
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain (full–2010)
http://www.oarsijournal.com/article/S1063-4584%2810%2900315-8/fulltext
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms (full-2010) http://www.mdpi.com/1424-8247/3/7/2163/htm
Bimodal control of stimulated food intake by the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20139974
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration. (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19916793
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473327/
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (full–2012)
http://ijnp.oxfordjournals.org/content/16/2/393.long
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity (full–2013) http://ijnp.oxfordjournals.org/content/16/10/2273
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews[tt_news]=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect (full–2015) http://www.hindawi.com/journals/crigm/2015/405238/
Current Status and Future of Cannabis Research (full–2015)
http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327 Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Concentration, population, and context-dependent effects of AM251 in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883874
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon? (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816312385
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28127623


BIPOLAR DISORDER
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21658778
Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22818174
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24126189
Is there a role for palmitoylethanolamide in the treatment of depression? (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24630855
Cannabis for Bipolar (news–2014) http/www.ladybud.com/2014/01/13/cannabis-for-bipolar/
The association between cannabis use and mood disorders: A longitudinal study (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25451420
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood. (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Endocannabinoid signaling in social functioning: an RDoC perspective (full – 2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256 Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033329
Cannabinoid hyperemesis syndrome and the onset of a manic episode (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27122104
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27710762
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27870392


BLADDER/URINARY FUNCTIONS
Functional role of cannabinoid receptors in urinary bladder (full-2010) http://www.indianjurol.com/article.asp?issn=0970- 1591;year=2010;volume=26;issue=1;spage=26;epage=35;aulast=Tyagi
Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20207474
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19733001
Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction (full–2010) http/www.jurology.com/article/S0022-5347%2810%2904713-0/fulltext
Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20207474
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full–2011) http/www.molecularpain.com/content/pdf/1744-8069-7-31.pdf
top
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21310467
Cannabinoids: potential targets for bladder dysfunction (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21290238
Cannabinoid mediated diuresis in mice (abst-2011) http/www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/617.6?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/23219540
Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/21930339
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22954177
Distribution and function of the endocannabinoid system in the rat and human bladder (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/23081739
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction (full–2013) http/onlinelibrary.wiley.com/doi/10.1002/nau.22442/full
Diuretic effects of cannabinoids (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Bladder function in a cannabinoid receptor type 1 knock-out mouse (full–2013) http/onlinelibrary.wiley.com/doi/10.1111/bju.12350/full
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23908133
Diuretic effects of cannabinoid agonists in mice (abst–2013) http/www.sciencedirect.com/science/article/pii/S0014299913007176
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24142157
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http/www.neurology.org/content/82/17/1556.long
Current and future drugs for treatment of MS-associated bladder dysfunction (full–2014) http/www.sciencedirect.com/science/article/pii/S187706571401728X
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24746881
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374388
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25467189
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
top
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015)
http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25575795
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25788026
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano afferent nerve fibers in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189783
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
Cannabinoid receptor expression in the bladder is altered in detrusor overactivity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26224382
The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26243021
Can Medical Marijuana Treat Multiple Sclerosis? (news–2015) http://www.webmd.com/multiple-sclerosis/features/medical-marijuana-multiplesclerosis?src=RSS_PUBLIC
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_14
New therapeutic strategies for the treatment of male lower urinary tract symptoms (full – 2016) https://www.dovepress.com/new-therapeutic-strategies-for-the-treatment-of-male-lower-urinary-tra-peerreviewed-article-RRU
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bju.13336/full
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26942594
Anandamide transporter-mediated regulation of the micturition reflex in urethaneanesthetized rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27256398
The endocannabinoid system – a target for the treatment of LUTS? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27377161 Potential Future Pharmacological
Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27927655
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28058780


BLISTERS/BLISTERING
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898


BLOOD-BRAIN BARRIER/BLOOD-SPINAL CORD BARRIER
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) (full–2010) http://ijnp.oxfordjournals.org/content/13/7/905.long
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors (full-2011) http/www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018490
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22678129
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
Multiple sclerosis and the blood-central nervous system barrier (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full-2013) http/www.sciencedirect.com/science/article/pii/S0969996113001939
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full-2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23831388
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension (abst-2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5558
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
top
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24819918
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24874648
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24929655
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington’s disease brain (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24978314
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/25015040
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http://www.sciencedirect.com/science/article/pii/S1043661814000814
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood Brain Barrier (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington’s disease brain (abst–2014) http://www.sciencedirect.com/science/article/pii/S0891061814000453
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459020/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795159/
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full-2015) http://tinyurl.com/obffgfh
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26376816
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen glucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the bloodspinal cord barrier permeability induced by ischemia-reperfusion injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26835555
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target (abst–2016) http://www.eurekaselect.com/141330/article
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00516


BLOOD/PLATELETS/PLASMA
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full-2010) http/www.jlr.org/content/51/6/1416.full.pdf+html
The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle (abst-2010) http/www.ncbi.nlm.nih.gov/pubmed/19200965
Anandamide extends platelets survival through CB(1)-dependent Akt signaling (abst-2010) http/www.ncbi.nlm.nih.gov/pubmed/19936621
Effect of Cannabis sativa on Hematological Indices in Rats and Men (full-2011) http/docsdrive.com/pdfs/ansinet/pjn/2011/313-316.pdf
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21664223
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full-2012) http/www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function (full-2013) http/jpet.aspetjournals.org/content/346/1/54.long
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (abst-2013) http/www.psyneuen-journal.com/article/S0306-4530%2813%2900292-8/abstract
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study. (full – 2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23585028
top
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst-2013) http/www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23702422
Mechanism of platelet activation induced by endocannabinoids in blood and plasma (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23789792
Critical issues in the analysis of endocannabinoids and related compounds in plasma: artifactual isomerization and ex-vivo enzymatic generation of 2-monoacylglycerols (full-2014) http/www.jlr.org/content/early/2014/03/07/jlr.D043794.long
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects (full-2014) http/onlinelibrary.wiley.com/doi/10.1002/oby.20728/full
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (full–2014) http://www.plosone.org/article/info%3Adoi %2F10.1371%2Fjournal.pone.0108282
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels (full-2014) http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614031/
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25427281
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s) (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24361246
Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/25068972
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9- Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (full–2015) http://www.jbc.org/content/early/2015/02/09/jbc.M114.618447.long
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full– 2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study (full–2015) http://www.biomedcentral.com/1756-0500/8/504
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling (full–2015) https://peerj.com/articles/1056/
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (full–2015) http://jn.nutrition.org/content/145/9/2169.long
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2- Arachidonoylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26460717
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=11367&path%5B%5D=35984 Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
Pre-hospital identification and post-recovery challenges of intoxication with synthetic cannabinoid containing legal high products such as ‘Exodus Damnation’ (full–2016) http://journals.sagepub.com/doi/full/10.1177/0036933016659177
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full – 2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Effects of activation of endocannabinoid system on myocardial metabolism. (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Cannabinoids and haemostasis. (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27383573
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300045
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Anandamide and its metabolites: what are their roles in the kidney? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100705
Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27151562
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591408
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595371
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816309021
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989579
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28011441
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28017680
Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28046144
Plasma endocannabinoid behaviour in total knee and hip arthroplasty. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28078867
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28108228
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo (abst–2017) http://pubs.rsc.org/en/Content/ArticleLanding/2017/PP/C6PP00337K#!divAbstract


BLOOD-PRESSURE/VASORELAXATION
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931560/
Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat (full-2011) http://ajpregu.physiology.org/content/301/6/R1765.full
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413845/
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045206/
Low-volume binary drug therapy for the treatment of hypovolemia (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21330941
top
Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors (full-2012) http://ajpregu.physiology.org/content/302/7/R876
Tolerance to Effects of High-Dose Oral {Delta}9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584989/
Serum contents of endocannabinoids are correlated with blood pressure in depressed women (full-2012) http://www.lipidworld.com/content/pdf/1476-511X-11-32.pdf
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912002671
Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22285599
Circulating anandamide and blood pressure in patients with obstructive sleep apnea (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23032139
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614708/
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537620/
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020800
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full – 2013) http://www.karger.com/Article/FullText/350094
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23340219
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23340220
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/654.15?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24292743
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats (abst–2013) https://www.ncbi.nlm.nih.gov/pubmed/23499700
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full-2014) http://jpet.aspetjournals.org/content/early/2014/01/15/jpet.113.209213.long
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries (full-2014) http://download.springer.com/static/pdf/387/art%253A10.1007%252Fs00210-014-0961-9.pdf?auth66=1396559334_2a7771f3b0767a5092c7c4a570374992&ext=.pdf
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
A new face of endocannabinoids in pharmacotherapy. Part I: Protective role of endocannabinoids in hypertension and myocardial infarction (full-2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/171_04_14_article.pdf
top
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full-2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats (full-2014) http://jpet.aspetjournals.org/content/early/2014/08/06/jpet.114.216036.long
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561046
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934539
The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane anesthetized rats (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24681436
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5558
Structural and functional characterization of hemp seed (Cannabis sativa L.) proteinderived antioxidant and antihypertensive peptides (abst–2014) http://www.sciencedirect.com/science/article/pii/S1756464613002594
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/ Effects of high-fructose diets on central appetite signaling and cognitive function. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/ Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. (full – 2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/343_06_15_article.pdf Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. (full – 2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492759/ What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension? (full – 2015) http://www.cmjournal.org/content/10/1/36 METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/ Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men. (full– 2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286 Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with dietinduced obesity (full – 2015) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.13056
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling induced vasoconstriction and hypertension (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595485
Alterations in the Medullary Endocannabinoid System contribute to age related impairment of Baroreflex Sensitivity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25636077
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25672659
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26173564
Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297305
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
Cannabinoid 2 receptoractivation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
Cannabinoids-Induced Vasodilation in Rat Mesenteric Artery: Possible Mechanisms of Action (abst–2015) http://www.fasebj.org/content/29/1_Supplement/948.6.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats (abst–2015) http://jpet.aspetjournals.org/content/356/2/456.abstract? sid=97527854-e2fb-4d74-ad96-6ab0744dc240
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003412
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (full – 2016) http://www.amjmed.com/article/S0002-9343(15)01024-4/fulltext
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression. (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists. (full – 2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries. (full – 2016) http://www.sciencedirect.com/science/article/pii/S104366181630113X
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982395/
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00210-016-1302-y
Pre-hospital identification and post-recovery challenges of intoxication with synthetic cannabinoid containing legal high products such as ‘Exodus Damnation’ (full–2016) http://journals.sagepub.com/doi/full/10.1177/0036933016659177
Effects of activation of endocannabinoid system on myocardial metabolism. (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516301643
Anandamide and its metabolites: what are their roles in the kidney? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100705
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Marijuana Use and Its Effects in Pregnancy. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27676325
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861247
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMPdependent vasorelaxant (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27890711


BONE MARROW
Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2975171/?toolubmed
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?toolubmed
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/22074629
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0146267
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long


BORDERLINE PERSONALITY DISORDER
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744119/
Identity disturbance and substance-dependence in patients with borderline personality disorder (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905504/
Cannabis use and suicidal ideations in high-school students (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
top
Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25041562
A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin (full–2015) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2015.15020216
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835


BORNA DISEASE
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981070/?tool=pubmed
Prospects for cannabinoid therapies in viral encephalitis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24021420


BOWEL DISORDERS
Achalasia, status post myotomy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Rectal spasms (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/791/
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez
The endocannabinoid system links gut microbiota to adipogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925525/
Endocannabinoid control of gastric sensorimotor function in man (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04259.x/full
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2009.01419.x/pdf
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability (full-2010) http://jpet.aspetjournals.org/content/335/1/92.full
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice. (full – 2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full-2010) http://www.freepatentsonline.com/EP2044935A1.html
Cannabinoids and the gut: New developments and emerging concepts (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20117132
Gut feelings about the endocannabinoid system (full-2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
Treatment of Crohn’s disease with cannabis: an observational study (full–2011) http/www.ima.org.il/FilesUpload/IMAJ/0/39/19985.pdf
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?toolubmed
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation (full–2011) http/www.nature.com/ajg/journal/v106/n1/pdf/ajg2010305a.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (full–2011) http/ajpgi.physiology.org/content/early/2011/11/28/ajpgi.00158.2011.full-text.pdf+html
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full – 2011) https/www.google.com/patents/US7884133?dqatent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21876860
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423254/
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full–2011) http/www.fasebj.org/content/25/8/2711.long
top
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21726418
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus (abst–2011) http/www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
Effects of Cannabinoid Agonists on Sheep Sphincter of Oddi in vitro (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21921665
Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology (abst–2011) http/www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/807.1?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Medical cannabis: the opportunity versus the temptation (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21745190
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis. (full – 2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility (full–2012) http/content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
The JNK inhibitor XG-102 protects against TNBS-induced colitis (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3302790/
The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01954.x/full
Endocannabinoid modulation of jejunal afferent responses to LPS (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01961.x/full
Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility (full–2012) http/www.jneurosci.org/content/32/30/10331.long
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3548934/
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3372737/
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3362100/
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069
Gut microbiota and the development of obesity (full–2012) http/scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full–2012) http/www.jleukbio.org/content/91/6/911.full
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22269477
top
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention (abst–2012) http/www.sciencedirect.com/science/article/pii/S1043661812000540
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22917662
Agents that act luminally to treat diarrhoea and constipation (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22945441
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078
Role of endogenous cannabinoid system in the gut (full-2013) http/www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Effect of high fat-diet and obesity on gastrointestinal motility (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3890396/
Cannabis Finds Its Way into Treatment of Crohn’s Disease (full–2013) http/www.karger.com/Article/Pdf/356512
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http/www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3677091/
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
A potential role for GPR55 in gastrointestinal functions (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3660623/
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23648372
Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23769745
Marijuana use patterns among patients with inflammatory bowel disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12158/full
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF–2013) http/www.europeanreview.org/article/3266
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23454360
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http/www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23706402
top
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23849204
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoidmediated gastroprotective effect in rats (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/24145131
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23972358
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24238999
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24275607
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst–2013) http/onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full–2014) http/ajpgi.physiology.org/content/307/2/G140
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst–2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Modulation of Gut-Specific Mechanisms by Chronic Δ9-THC Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24400995
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25348153
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25378491
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24460851
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24641009
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24818658
Palmitoylethanolamide Regulates Development of Intestinal Radiation Injury in a Mast Cell-Dependent Manner (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213290/
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25199471
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25263804
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25281429
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25531553
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24444427
top
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24631413
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24813296
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuroneuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24911079
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst-2014) http/onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
Colitis generates remote antinociception in rats: the role of the L arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24964851
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24407485
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26075589
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study (full–2015) http://www.karger.com/Article/FullText/375454
top
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (full–2015)
http://www.turkjgastroenterol.org/sayilar/281/buyuk/639-43.pdf
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382707/
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Pharmacogenetics in irritable bowel syndrome (full – 2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i37/10704.htm
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144270
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (full–2015) http://www.jbc.org/content/290/5/2902.long
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25757568
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572435
Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600392/
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684407
The GPR55 antagonist CID16020046 protects against intestinal inflammation (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26227635
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918633/
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25869205
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_14
The long-term functional consequences of acute infectious diarrhea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628101
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638765
Endocannabinoids – at the crossroads between the gut microbiota and host metabolism (abst–2015) http://www.nature.com/nrendo/journal/v12/n3/full/nrendo.2015.211.html
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome (full–2016) http://www.jlr.org/content/early/2016/02/17/jlr.M066308.long
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes (full–2016) http://jpet.aspetjournals.org/content/early/2016/03/21/jpet.116.232553.long
top
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids (full – 2016) http://www.sciencedirect.com/science/article/pii/S1995764516300712
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919975/
Unusual side effect of cannabis use: acute abdomen due to duodenal perforation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936980/
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment (full–2016) http://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-016-0129-0
Endocannabinoids in the Gut (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859716/
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/27431236
Cannabis intake and intussusception: an accidental association? (link to PDF–2016) https://online.reed.es/fichaArticulo.aspx?iarf=683765745237-413275199162
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis. (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26817719
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article
Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26991932
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115 Endocannabinoids in the gut (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27538961
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27590030
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929 Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686064
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Cannabinoids and GI Disorders: Endogenous and Exogenous (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27699625
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis (abst–2016) http://link.springer.com/article/10.1007%2Fs10620-016-4404-y
Textual research on Han-Chinese formulae collected in Tubo medical manuscript unearthed in ‘Bum-pa-Che Tower (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103984
Role of cannabis in digestive disorders (abst–2017) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=3


BRAIN
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice (full-2010) http://www.jneurosci.org/content/30/18/6273.long
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72 Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20085790 Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470 (full-2011) http://www.hindawi.com/journals/ijmi/2011/548123/
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327 Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
Marijuana Compound Improves Brain And Liver Function In Animal Model Of Hepatic Encephalopathy (news-2011) http://www.norml.org/index.cfm?Group_ID=8464
Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat (abst–2011) http://www.sciencedirect.com/science/article/pii/S0028390811000177
Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510355/
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat Brain (full–2012) http://www.hindawi.com/isrn/pharmacology/2012/276902/
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (full–2012) http://ijnp.oxfordjournals.org/content/16/2/393.long
Multiple functions of endocannabinoid signaling in the brain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22524785?dopt=Abstract
CHRONIC, NONINVASIVE GLUCOCORTICOID ADMINISTRATION SUPPRESSES LIMBIC ENDOCANNABINOID SIGNALING IN MICE (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697830/
Cannabinoid Receptor CB2 Modulates Axon Guidance (link to PDF-2012) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.727.7765&rank=63&q=cannabinoid&osm=&ossid=
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
The Endocannabinoid System and the Brain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22804774
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22391102
Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22155282
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach (abst-2012) http://www.sciencedirect.com/science/article/pii/S0165027011007059
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812001636
top
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537620/
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full–2013) http://www.karger.com/Article/FullText/350094
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to download–2013) http://www.eurekaselect.com/107948/article
Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain (link to PDF–2013) http://www.eurekaselect.com/107971/article
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22763024
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454443
Imaging dopamine transmission parameters in cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24513022
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454443
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23020923
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full–2014) http://jpn.ca/wp-content/uploads/2014/12/39-6-140081.pdf
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25539508
Imaging dopamine transmission parameters in cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24513022
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374096
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models (full–2014) http://www.nature.com/tp/journal/v4/n5/full/tp201431a.html
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/25231848
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25452006
Endocannabinoid signalling and the deteriorating brain (abst–2014) http://www.nature.com/nrn/journal/v16/n1/abs/nrn3876.html
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study (full–2015)
http://www.karger.com/Article/FullText/375454
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015)
http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action. (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Combined effects of marijuana and nicotine on memory performance and hippocampal volume (full–2015) http://www.sciencedirect.com/science/article/pii/S0166432815301005
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/ 
top
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor (full–2015) http://jcb.sagepub.com/content/early/2015/09/23/0271678X15606923.long
Impact of CB1 Receptor Deletion on Visual Responses and Organization of Primary Visual Cortex in Adult Mice (full–2015) http://iovs.arvojournals.org/article.aspx?articleid=2474494&resultClick=1
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume (full–2015) http://ijnp.oxfordjournals.org/content/18/10/pyv061 Tetrahydrocannabivarin (THCv) reduces Default Mode Network and increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/10/ijnp.pyv092.long
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ejn.13118/full
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala (full–2015) http://www.sciencedirect.com/science/article/pii/S002839081530201X
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
Age-related changes in the endocannabinoid system in the mouse hippocampus (full–2015) http://www.sciencedirect.com/science/article/pii/S0047637415300099
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/ Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532757/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition (full-2015) http://www.pnas.org/content/113/1/26.long
Mechanisms of stress in the brain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933289/
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure (full–2015) http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2429550
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
A Hardwired Circuit Supplemented with Endocannabinoids Encodes Behavioral Choice in Zebrafish (full–2015) http://www.cell.com/current-biology/fulltext/S0960-9822(15)01013-1
The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25779032
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001264
Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26021304
Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201 (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26032255
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26071625
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26168676
Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215006387
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26237321
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of FoodRestricted Rats: Involvement of CB1 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26354043
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26432420
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26514581
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques (abst–2015) http://link.springer.com/article/10.1007%2Fs11481-015-9645-6
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.n lm.nih.gov/pubmed/26638768
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26663094
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708672
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-014-1907-9
Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25484353
Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715000647
Nicotine Changes Marijuana’s Effect on the Brain (news & abstract-2015) http://neurosciencenews.com/hippocampal-volume-nicotine-marijuana-2457/
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152482 Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016300192
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016302907
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Synthetic cannabinoids revealing adrenoleukodystrophy (full–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983615/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470
PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0257-8
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923145/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8 Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00415/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol SelfAdministration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. (full – 2016) http://learnmem.cshlp.org/content/23/7/349.long
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982395/
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00210-016-1302-y
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031696/
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075776/
α/β-Hydrolase Domain 6 in the Ventromedial Hypothalamus Controls Energy Metabolism Flexibility (full – 2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)31373-0 Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Hippocampal harms, protection and recovery following regular cannabis use (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015201a.html
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system (click “Full Text Links” to download–2016) https://www.ncbi.nlm.nih.gov/pubmed/27903595
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats (link to PDF–2016) http://press.endocrine.org/doi/10.1210/en.2016-1516?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats (link to PDF–2016) http://jpn.ca/articles-in-press/41-6-150363/
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent-case report (link to download–2016) http://www.mppt.hu/folyoirat/1/abstract/? vol=18&issue=3&elsooldal=162
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889592
Cannabinoids in the Brain: New Vistas on an Old Dilemma (article–2016) http://www.hindawi.com/journals/np/2016/9146713/
Harvesting Benefits from Cannabinoids (article–2016) http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
Treating Depression in Alcoholics (news & abst–2016) http://neurosciencenews.com/alcoholism-depression-psychology-3541/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Protein purification and cloning of diacylglycerol lipase from rat brain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26790472
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26804027
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26811312
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820636
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833913
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396 Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0891061815300405
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26946127
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27021494
Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27063786 Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303449
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Interaction between paired-pulse facilitation and long-term potentiation during the stimulation of the cannabinoid and vanilloid systems in the dentate gyrus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27130895
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630256X
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415301494
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27167970
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27169390
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27206544
Neural mechanisms of sensitivity to peer information in young adult cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27068178
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27208730
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816303187
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
Experimental Evidence that 3-Methylglutaric Acid Disturbs Mitochondrial Function and Induced Oxidative Stress in Rat Brain Synaptosomes: New Converging Mechanisms (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27278758
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27266665
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27305347
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27345297
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+) mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27385208
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27441365
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27450559 Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses (abst–2016) http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract Adolescent cannabis use: What is the evidence for functional brain alteration? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27514709
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27528659
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305997
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595886
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623930
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced Tinnitus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27658122
Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27663967
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27707960
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27717809
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304579
Endocannabinoids and sleep (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27769788
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27772772
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797833
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Cannabinoid Modulation of Memory Consolidation within the Cerebellum (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716302969
Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861247
Buzz Juice: Neurological sequelae of synthetic cannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27865819
Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in dextromethorphan/morphine-induced amnesia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916307282
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids. (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27870392
Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889577
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Cannabinoid modulation of zebrafish fear learning and its functional analysis investigated by c-Fos expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302854
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? (abst–2016) http://link.springer.com/article/10.1007%2Fs00441-016-2544-1
Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116300555
Chapter Eight – The Endocannabinoid System and Anxiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28061971
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28042028
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism (full–2017) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0783-4 Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. (link to download-2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28092019
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28100744
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103941
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28106377
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28109780
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28127623
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675
Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28134998


BRAIN TRAUMA
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full-2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?toolubmed
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Endocannabinoids and traumatic brain injury (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950/?toolubmed
The dual neuroprotective-neurotoxic profile of cannabinoid drugs (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
top
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21315768
Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury (abst–2011) http/www.unboundmedicine.com/medline/ebm/record/21332427/abstract/Acute_effects_of_a_selective_cannabinoid_2_receptor_agonist_on_neuroinflammation_in_a_murine_model_of_traumatic_brain_injury_
Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3310878/?toolubmed
New metabolic pathway for controlling brain inflammation (news-2011) http/www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report (full-2012) http/file.scirp.org/Html/9-2500130_16958.htm
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268782/
Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22696266
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)- tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22821081
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full–2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF-2013) http/www.mdpi.com/1422-0067/14/12/23341
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (full–2013) http://cercor.oxfordjournals.org/content/25/1/35.long
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23960212
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http/www.eurekaselect.com/107976/article
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/22371074
top
Resuscitation from experimental traumatic brain injury by magnolol therapy (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23721932
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014) http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24671870
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24819918
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24937045
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/25058046
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348366/
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet (link to PDF-2014) http/www.ncbi.nlm.nih.gov/pubmed/24993629
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24874648
Effect of marijuana use on outcomes in traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Visual deficits in mice after mild traumatic brain injury produced by primary overpressure blast are alleviated by the novel CB2 drug SMM189 (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271359&resultClick=1
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full-2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full-2015) http://www.mdpi.com/1422-0067/16/1/758/htm
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways (full-2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
top
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506688/
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury (full–2015) http://jcb.sagepub.com/content/35/3/443.long
Correction to – Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-Like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury (full–2015) http://jcb.sagepub.com/content/35/4/706
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury? (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0092/jbcpp-2015-0092.xml
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (full-2015) http://tinyurl.com/p8xwgww
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721934
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst-2015)
http://www.ncbi.nlm.nih.gov/pubmed/25917763
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst-2015)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury (full–2016) http://www.sciencedirect.com/science/article/pii/S0014488616300619
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0257-8
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Endocannabinoids in Cerebrovascular Regulation (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27189876
CB1 Receptor Antagonism Prevents Long-Term Hyperexcitability after Head Injury by of Dynorphin-KOR System and mGluR5 in Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262683
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302 Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810514
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full


BREASTFEEDING/LACTATION/INFANT APPETITE
Effects of increasing amounts of hempseed cake in the diet of dairy cows on the production and composition of milk (full-2010) http://tinyurl.com/q7e8vz9
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21330091
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice (full-2012) http://www.dmsjournal.com/content/4/1/35
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst-2012) http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
top
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24060654
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural and neuronal responses during lactation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23417606
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24060654
Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24377270
The endocannabinoid anandamide during lactation increases body fat content and CB1 receptor levels in mice adipose tissue (full-2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491858/
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Oxylipins, endocannabinoids, and related compounds in human milk: levels and effects of storage conditions (abst-2016) http://www.sciencedirect.com/science/article/pii/S1098882315300174
Dietary conjugated linoleic acid supplementation alters the expression of genes involved in the endocannabinoid system in the bovine endometrium and increases plasma progesterone concentrations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262886


BULIMIA
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
The genetics of eating disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243475
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22542985
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
top
Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population (full-2014) http://onlinelibrary.wiley.com/doi/10.1002/mgg3.69/full
Endocannabinoids and Metabolic Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_10
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268


BURNING MOUTH SYNDROME
Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis (full-2013) http://www.hh.um.es/pdf/Vol_29/29_4/Borsani-29-523-533-2014.pdf
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831


BURN INJURIES
Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanic Thermal Hyperalgesia after Burn Injury (abst-2014) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1936541&resultClick=3
Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675612/


BUSINESS OF CANNABIS/CANNABIS JOBS
A Sociological Theory of Drug Sales, Gifts, and Frauds (full–2010) http://journals.sagepub.com/doi/full/10.1177/0011128710386199
The case for small-scale domestic cannabis cultivation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176465
What can we learn from the Dutch cannabis coffeeshop system? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21906196
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale growers from going large scale (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23036648
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24180513
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Are users’ most recent drug purchases representative? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25008105
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038957/
Analysis of a commerical marijuana e-cigarette formulation (abst–2016) (This article has a delayed release and will be available in PMC on June 1, 2017) https://www.ncbi.nlm.nih.gov/pubmed/27059691
Underbanked: Cooperative Banking as a Potential Solution to the Marijuana-Banking Problem (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27008718
top

Advertisements